Evaluation of Benzamide Derivatives as New Influenza A Nucleoprotein Inhibitors
Open Access
- 1 January 2016
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Medicinal Chemistry
- Vol. 06 (03), 43-50
- https://doi.org/10.4236/ojmc.2016.63004
Abstract
Virus nucleoprotein (NP) is an emerging target for drug development for Influenza. We designed benzamide derivatives as new inhibitors of NP that demonstrate good potency in blocking influenza A. Screening revealed that compound 39 was the most potent molecule in the series, exhibiting IC50 values of 0.46 and 0.27 μM in blocking the replication of H3N2 (A/HK/8/68) and (A/WSN/33) influenza A viral strains. The observed inhibition of viral replication correlated well with cytopathic protection. Furthermore, based on computational analysis and fluorescence microscopy, it was determined that compound 39 inhibited nuclear accumulation by targeting influenza A viral nucleoproteins. Finally, the rodent pharmacokinetic profile of compound 32 displayed half-life of greater than 4 hours and bioavailability greater than 20%, suggesting this class of molecules had drug-like properties.Keywords
This publication has 22 references indexed in Scilit:
- Structure-Based Discovery of the Novel Antiviral Properties of Naproxen against the Nucleoprotein of Influenza A VirusAntimicrobial Agents and Chemotherapy, 2013
- Design, Synthesis, and in Vitro Biological Evaluation of 1H-1,2,3-Triazole-4-carboxamide Derivatives as New Anti-influenza A Agents Targeting Virus NucleoproteinJournal of Medicinal Chemistry, 2012
- E339…R416 salt bridge of nucleoprotein as a feasible target for influenza virus inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2011
- Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomersProceedings of the National Academy of Sciences of the United States of America, 2011
- Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivoPLoS Currents, 2011
- High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activityProceedings of the National Academy of Sciences of the United States of America, 2010
- Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arraysBiochemical and Biophysical Research Communications, 2010
- Pandemic Influenza: An Inconvenient MutationScience, 2009
- Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolutionNature, 2005
- Variation of Influenza A, B, and C VirusesScience, 1982